XML 102 R90.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENT INFORMATION - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Disaggregation of Revenue [Line Items]        
Revenues $ 2,403 $ 2,167 $ 4,556 $ 4,111
Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 1,085 946 2,022 1,769
Devices        
Disaggregation of Revenue [Line Items]        
Revenues 547 496 1,059 975
OTC        
Disaggregation of Revenue [Line Items]        
Revenues 490 461 925 855
Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 258 243 502 469
Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 23 21 48 43
Salix        
Disaggregation of Revenue [Line Items]        
Revenues 558 557 1,057 1,053
Salix | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 557 558 1,056 1,054
Salix | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 1 (1) 1 (1)
International        
Disaggregation of Revenue [Line Items]        
Revenues 276 259 541 506
International | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 63 60 121 117
International | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
International | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 41 39 80 78
International | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 157 148 310 286
International | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 15 12 30 25
Solta Medical        
Disaggregation of Revenue [Line Items]        
Revenues 102 88 190 161
Solta Medical | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 102 88 190 161
Solta Medical | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified        
Disaggregation of Revenue [Line Items]        
Revenues 251 228 453 425
Diversified | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 220 194 391 356
Diversified | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 2 1 3 3
Diversified | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 25 27 50 54
Diversified | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 4 6 9 12
Bausch + Lomb        
Disaggregation of Revenue [Line Items]        
Revenues 1,216 1,035 2,315 1,966
Bausch + Lomb | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 245 134 454 242
Bausch + Lomb | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 445 408 869 814
Bausch + Lomb | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 447 421 842 774
Bausch + Lomb | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 76 68 142 129
Bausch + Lomb | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues $ 3 $ 4 $ 8 $ 7